#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm Epilepsy with myoclonic-atonic seizures CDKL5 deficiency disorder Osteomyelitis Primary mediastinal large B-cell lymphoma Ocular lymphoma Anal cancer recurrent Idiopathic pulmonary fibrosis Ewing's sarcoma recurrent Anti-HLA antibody test positive Myeloproliferative neoplasm Non-small cell lung cancer Angiosarcoma non-metastatic Medullary thyroid cancer Progressive familial intrahepatic cholestasis More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Basic Information Lysosomal storage disorder – Treatment Synovial sarcoma metastatic – Life with Disease Isodicentric chromosome 15 syndrome – Diagnostics Behcet’s syndrome Bronchopulmonary dysplasia – Treatment Richter’s syndrome – Diagnostics Anaplastic thyroid cancer – Trials in Disease Osteosarcoma metastatic – Life with Disease Hereditary optic atrophy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phleum Pratense Pollen Extract Cefiderocol Cocarboxylase Tetrahydrate Talquetamab Abt-494 RO7268489 Sebetralstat NALOXEGOL Lactic Acid Cyanocobalamin Placebo Metoclopramide Cefuroxime Axetil Odm-208 Lufepirsen AUR200 Ranitidine Hydrochloride Ifezuntirgene Inilparvovec A/H1N1 INFLUENZA VACCINE Levofloxacin More therapies…

    Learn about Your Condition

    Rectal cancer stage II Cervix carcinoma Erosive oesophagitis Haemodynamic instability Alcohol use disorder Extra-osseous Ewing's sarcoma Respiratory failure Crigler-Najjar syndrome Osteotomy Invasive breast carcinoma Spinal cord injury Hepatitis B Gastrointestinal carcinoma Alagille syndrome Hepatic cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Vinblastine Sulfate
    • Cladribine
    France Germany Poland

  • Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • OLVEREMBATINIB
    • Imatinib Mesilate
    • Ponatinib
    Bulgaria Czechia France Germany Greece Hungary +3

  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Sodium Chloride
    • Apixaban
    Bulgaria Hungary Latvia Lithuania Poland Romania

  • Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia refractory
    • T-cell type acute leukaemia
    • Acute myeloid leukaemia
    Spain

  • Study of TdT-3 cell therapy safety in patients aged 1 year and older with relapsed or refractory acute leukemia or lymphoblastic lymphoma

    Recruiting

    2 1 1
    Norway

  • Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate Ph. Eur.
    • Treosulfan
    • Venetoclax
    Germany
Previous Page
1 … 5 6 7 8 9 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!